Analytical assessment of ortho clinical diagnostics high-sensitivity cardiac troponin I assay

Peter A Kavsak1,2, Tara Edge3, Chantele Roy3

  • 1McMaster University, Hamilton, ON, Canada.

Insights

The Ortho VITROS high-sensitivity cardiac troponin I assay shows excellent clinical performance for myocardial infarction detection. However, it yields lower results compared to other assays and has differences between serum and plasma. Standardization is needed.

Area of Science:

  • Clinical Chemistry
  • Cardiovascular Diagnostics
  • Biomarker Assay Evaluation

Background:

  • High-sensitivity cardiac troponin I (hs-cTnI) assays are crucial for diagnosing myocardial infarction (MI).
  • Standardization across different manufacturers remains a challenge, impacting clinical interpretation.

Purpose of the Study:

  • To analytically evaluate the Ortho Clinical Diagnostics VITROS hs-cTnI assay.
  • To compare its performance in serum and lithium heparin (Li-Hep) plasma against other hs-cTnI assays.

Main Methods:

  • Assessed limit of detection (LoD), imprecision, interference, and stability for the VITROS hs-cTnI assay in serum and Li-Hep plasma.
  • Performed Passing-Bablok regression analyses and Receiver-operating characteristic (ROC) curve analyses in an emergency department (ED) population for MI detection.

Main Results:

  • VITROS hs-cTnI assay demonstrated an LoD of 0.73 ng/L (serum) and 1.4 ng/L (Li-Hep).
  • Serum showed superior analyte stability compared to Li-Hep plasma, which was also affected by hemolysis.
  • The assay yielded proportionally lower concentrations in Li-Hep plasma (slope=0.85) and compared to other hs-cTnI assays in serum.
  • Achieved an area under the curve (AUC) of 0.974 for MI detection in the ED study, comparable to other hs-cTn assays.

Conclusions:

  • The VITROS hs-cTnI assay exhibits excellent clinical performance for MI detection, comparable to other hs-cTn assays.
  • Significant differences exist between serum and Li-Hep plasma results, highlighting the need for matrix-specific interpretation.
  • Lack of standardization among hs-cTnI assays necessitates further investigation and harmonization efforts.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
117
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
631
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
137
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
451
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
236
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
415